ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 434 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $904,141 | +3.9% | 10,539 | 0.0% | 0.09% | +10.6% |
| Q1 2024 | $870,311 | +23.8% | 10,539 | 0.0% | 0.08% | +18.1% |
| Q4 2023 | $703,162 | -0.7% | 10,539 | 0.0% | 0.07% | -13.3% |
| Q3 2023 | $707,799 | +18.3% | 10,539 | +19.2% | 0.08% | +23.9% |
| Q2 2023 | $598,489 | +14.0% | 8,839 | -8.9% | 0.07% | +4.7% |
| Q1 2023 | $524,824 | -48.3% | 9,701 | -46.5% | 0.06% | -74.2% |
| Q2 2022 | $1,016,000 | -21.2% | 18,122 | 0.0% | 0.25% | -5.0% |
| Q1 2022 | $1,289,000 | -45.5% | 18,122 | -50.0% | 0.26% | +7.9% |
| Q4 2021 | $2,366,000 | +74.0% | 36,244 | +100.0% | 0.24% | -18.5% |
| Q3 2021 | $1,360,000 | +491.3% | 18,122 | +386.6% | 0.30% | +440.0% |
| Q4 2018 | $230,000 | -65.2% | 3,724 | -56.0% | 0.06% | -57.7% |
| Q3 2018 | $660,000 | -60.0% | 8,464 | -65.2% | 0.13% | -61.3% |
| Q2 2018 | $1,649,000 | +9.4% | 24,355 | -7.6% | 0.34% | +5.3% |
| Q1 2018 | $1,507,000 | +1.1% | 26,367 | -12.6% | 0.32% | -23.3% |
| Q4 2017 | $1,491,000 | – | 30,177 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
| Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
| MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
| Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
| REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
| Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
| Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
| GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
| BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |